Clinical trials
Recruiting Myeloproliferative Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2015 | 1 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 10 |
| 2025 | 9 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| National Cancer Institute (NCI) | 4 |
| City of Hope Medical Center | 3 |
| Incyte Corporation | 3 |
| Dana-Farber Cancer Institute | 2 |
| Fred Hutchinson Cancer Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| University of Alabama at Birmingham | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myeloproliferative Disorders | 52 |
| Leukemia, Myeloid, Acute | 25 |
| Myelodysplastic Syndromes | 25 |
| Primary Myelofibrosis | 20 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 |
| Leukemia | 12 |
| Thrombocythemia, Essential | 10 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 9 |
| Lymphoma, Non-Hodgkin | 9 |
| Polycythemia Vera | 9 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.